权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Research Project 2

研究项目2

基本信息

批准号：
10738443
负责人：
Juliet Iwelunmor
金额：
$ 23.38万
依托单位：
WASHINGTON UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-09-19 至 2028-08-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10738443
关键词：
Adult Africa African Automobile Driving Birth Cancer Control Caring Cessation of life Child China Chronic Hepatitis B Clinic Clinical Communities Community Developments Community Health Aides Consolidated Framework for Implementation Research Country Creativeness Data Decentralization Dose Elements Engineering Equity Evaluation Face Guidelines HBV Liver Cancer Health Services Hepatitis Hepatitis B Hepatitis B Infection Hepatitis B Transmission Hepatitis B Vaccines Hepatitis B Virus Home Hospitals Hour Hybrids Immunity Immunization Individual Infant Intervention Liver diseases Malignant neoplasm of liver Measures Medicine Mothers National Cancer Institute Newborn Infant Nigeria Nigerian Persons Policies Population Pregnant Women Prevention Primary carcinoma of the liver cells Printing Protocols documentation Randomized, Controlled Trials Recommendation Records Request for Applications Research Research Methodology Research Project Grants Risk Services Site Time Training United States National Academy of Sciences United States National Institutes of Health Vaccination Vaccines Vertical Disease Transmission chronic infection cohort community clinic community engagement concept mapping crowdsourcing effectiveness evaluation effectiveness/implementation design emerging adult implementation outcomes implementation process implementation research implementation science implementation strategy infant infection innovation low and middle-income countries mathematical model neonatal infection post implementation preference primary outcome secondary outcome standard care testing uptake uptake vaccine acceptance vaccine delivery

项目摘要

Every hour, over 150 people die of hepatitis-related liver diseases in African countries like Nigeria, including hepatocellular carcinoma (HCC) and other liver cancers. Much of this death is attributable to the hepatitis B virus (HBV). A hepatitis B birth dose (HepB-BD) vaccine initiated within 24 hours of birth, followed by three additional pentavalent HBV vaccines (at six, 10, and 14 weeks after birth), provide durable immunity, substantially decreasing the risk of HBV and liver cancer. Nigerian national guidelines recommend HepB-BD vaccination for all newborns and provides them for free as part of the national immunization protocol, yet uptake is suboptimal, highlighting the need for implementation science research to develop locally relevant strategies to increase HepB-BD vaccine uptake. We propose a crowdsourcing approach to enhance timely coverage of HepB-BD vaccination in Nigeria. Crowdsourcing has a group of people solve all or part of a problem, then implement selected solutions. Our team used crowdsourcing to develop messages promoting HBV testing uptake, inform global hepatitis guidelines, and enhance hepatitis community engagement in low and middle-income countries (LMICs). Our study will focus on developing and implementing strategies to increase HepB-BD vaccination at community clinics, home births, and other sites outside of hospitals where most pregnant women receive care. The Consolidated Framework for Implementation Science Research (CFIR) and concept mapping will guide our evaluation of factors influencing uptake and sustainment. Our specific aims are: 1) To determine pregnant women's preferences on HepB-BD vaccination using community-engaged crowdsourcing research and finalize an implementation strategy to increase HepB-BD vaccination; 2) To determine the effectiveness of a finalized crowdsourced HepB-BD vaccination intervention among a cohort of pregnant women using a community-based clinic-level cluster RCT. Trained community health workers will implement the final intervention in a cluster randomized control trial of the crowdsourced intervention versus standard care (i.e. printed guidelines) among a cohort of 720 dyads (pregnant women and newborns) at 36 community-based clinics (n=1440); and 3) To use mixed methods research to determine multi-level factors that influence uptake and sustainment of crowdsourced HepB-BD vaccination over time. Primary outcome is HepB-BD vaccination ascertained by clinic records. Secondary outcome is service sustainment at the community-based clinic level, defined here as the percent sustainment of core elements of the final campaign measured 12 months after the trial, with sustained benefits and capacity for implementation at each community-based clinic. Our study is responsive to the U54 request for applications for global implementation science for equitable cancer control and and the strategic priorities of the National Cancer Institute. This study will provide a unique opportunity to expand HBV vaccine coverage, driving equitable implementation science research in settings traditionally under-represented in implementation science.

在尼日利亚等非洲国家，每小时有150多人死于与肝炎有关的肝病